Intellectus Partners, LLC Neurocrine Biosciences Inc Transaction History

Intellectus Partners, LLC

  • $441 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$96.16 - $135.15 $182,704 - $256,785
-1,900 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $161,671 - $247,684
1,900 New
1,900 $232,000
Q4 2018

Feb 14, 2019
SELL
$68.32 - $124.36 $129,807 - $236,284
-1,900 Closed
0 $0
Q2 2017

Aug 15, 2017
BUY
N/A
1,900
1,900 $87,000

Others Institutions Holding NBIX

# of Institutions
653
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Intellectus Partners, LLC Portfolio

Follow Intellectus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email